Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huachansu and TACE in advanced hepatocellular carcinoma
NCT01715532Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Jul 2012
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cinobufacini in hepatocellular carcinoma (HCC), sponsored by Fudan University. Status: unknown.
02
Drugs
cinobufacini
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01715532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01715532.